ADC Contract Manufacturing Market ADC Contract Manufacturing Market Report Covering Size, Trends and Growth
According to Shivani Zoting, who specializes in biotechnology, pharmaceutical CDMO, and oncology therapeutics market research, with 5+ years of experience in market research and industry analysis. Her research reveals that the ADC Contract Manufacturing Market is projected to grow from USD 7.68 billion in 2026 to USD 22.88 billion by 2035, driven by rising ADC pipelines, outsourcing trends, and technological advancements. The analysis covers key segments including service type, payload type, linker type, and conjugation technology, while highlighting North America’s market leadership and Asia Pacific’s rapid growth. The research also evaluates leading companies such as Lonza Group, WuXi Biologics, Samsung Biologics, Catalent, and Piramal Pharma Solutions shaping the competitive landscape.
Last Updated : 14 July 2026
Category: Pharmaceuticals
Insight Code: 6870
Format: PDF / PPT / Excel